Randomized, Double-Blind, Placebo-Controlled, Single-Center Clinical Study, where participants will take the Daily Supplement, and record Daily Symptoms, two clinical visits where Hydrogen and Methane Breath Test (HMBT) will be conducted, Abdominal Circumference Measurement will be taken, and two Self Reported Validated Questionnaires: Visual Analogue Scale (VAS) and the Quality of Life Questionnaires.

Inclusion Criteria:

1. Healthy Adults aged 18-65 years
2. Reported bloating and/or distention occurring at least once per week for the past 6 months, with symptoms actively present during the past 3 months
3. Willingness to avoid probiotics, antibiotics, or other supplements during the study period (unless approved by investigators)
4. Ability to provide informed consent and comply with all protocol requirements

Exclusion Criteria:

1. Diagnosed gastrointestinal diseases (e.g., inflammatory bowel disease, celiac disease, GI malignancies)
2. Use of antibiotics, laxatives, or probiotics within the past 4 weeks
3. Uncontrolled diabetes mellitus
4. Presence of mood disorders or psychiatric illness that may affect symptom perception or study compliance
5. Immunodeficiency, autoimmune conditions, or chronic inflammatory conditions
6. Excessive alcohol intake (>14 drinks/week for men, >7 drinks/week for women)
7. Use of medications known to affect gut motility or gas production (e.g., opioids, anticholinergics)
8. Pregnant or breastfeeding women
9. Use of systemic corticosteroids or immunosuppressant drugs.
10. History of reaction to the category of product tested
11. Other diseases or medications that might directly interfere in the study or put the subject's health under risk.
12. Employee of CRO or product manufacturer